GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the BARD1 brct mutant

Analyse Crystal structure of the BARD1 brct mutant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6M14
Type
protein
Length
418 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BRCA1-associated ring domain protein 1
EC
2.3.2.27
UniProt
Q99728
Ligands
SO4
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, ABRCA1-associated ring domain protein 1 (EC 2.3.2.27)protein20934% helix, 16% strandQ99728

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13760.690.8144empty
23110.640.8036empty

Interfaces

1 interface between chains.

  • B–A · 787 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 6M14 · Crystal Structure of the BARD1 BRCT Mutant · the same entry in another collection · chain B against B, TM-score 1.00
  • Q99728 · AlphaFold monomer V2.0 prediction for BRCA1-associated ring domain protein 1 (Q99728) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.